Genmab A/S (GMAB)
32.25
-1.60
(-4.73%)
USD |
NASDAQ |
Jan 16, 16:00
32.26
0.00 (0.00%)
After-Hours: 20:00
Genmab Price: 32.25 for Jan. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 214.35 |
| Krystal Biotech, Inc. | 285.04 |
| Novo Nordisk A/S | 62.33 |
| Ascendis Pharma A/S | 205.83 |
| Evaxion AS | 4.55 |
Price Related Metrics
| PE Ratio | 13.70 |
| PS Ratio | 5.646 |
| PEG Ratio | 0.108 |
| Price to Book Value | 3.449 |
| Price to Free Cash Flow | 16.68 |
| Earnings Yield | 7.30% |
| Market Cap | 19.83B |
| PEGY Ratio | 0.108 |
| Operating PE Ratio | 15.32 |
| Normalized PE Ratio | 13.63 |